The National Post has an article on shortages in the supply of about 10-15 generic drugs.
The generic drug companies point to manufacturing and supply problems - and remember that this is a global industry, so we're often talking about off-shore supply problems - but the journalists can't help wondering if this reflects the recent changes in generic drug pricing regimes.
A simple little decision brings an important reminder
-
The Davies v Lazer Safe decision is a timely reminder that in IP disputes,
leverage often sits in the procedural details. The Court clarified that an
old f...
4 days ago

No comments:
Post a Comment